PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice

The increased PD-L1 expression induces poorer prognosis in melanoma. The small molecule inhibitors of PD-1/PD-L1 pathways have been an encouraging drug development strategy because of good affinity and oral bioavailability without immunogenicity and immunotoxicities of PD-1/PD-L1 antibodies. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhengping, Yu, Pengfei, Du, Guangying, Wang, Wenyan, Zhu, Haibo, Li, Ning, Zhao, Huijuan, Dong, Zhaoju, Ye, Liang, Tian, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098565/
https://www.ncbi.nlm.nih.gov/pubmed/32214351
http://dx.doi.org/10.1371/journal.pone.0228339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098565/
https://www.ncbi.nlm.nih.gov/pubmed/32214351
http://dx.doi.org/10.1371/journal.pone.0228339

Ejemplares similares